With this lag in mind, De Leo and colleagues recently identified small molecule drug candidates [100] that decrease the accumulation of the autophagy substrate p62/SQSTM1 and restore the autophagy–endolysosome degradative pathways, which are compromised in different models and cell systems of cystinosis [100]. The gene discussed is SQSTM1; the disease is cystinosis.